The Experts in FDA and USDA Regulatory Matters
EAS Consulting Group is a leading provider of regulatory compliance solutions to industries regulated by FDA, USDA, and supporting agencies. Our team of consultants provide expert guidance for all of your regulatory requirements.
Got a Question?
Contact Us Today for a Complimentary Consultation!
Food
Learn More
Dietary Supplements
Learn More
Pharmaceuticals
Learn More
Medical Devices
Learn More
Tobacco
Learn More
Cosmetics
Learn More
Veterinary
Learn More
Cannabis
Learn More
Our Services: Consulting • Submissions • Auditing • Training • Legal Support
Learn With Us
Seminars
Transition from Computer System Validation (CSV) to Computer Software Assurance (CSA)
The life science industries, including pharmaceutical, medical device, biotechnology, biological, and tobacco and tobacco-related products continue to embrace new technology to improve delivery of quality products in compliance with FDA. In addition, we’ve seen a trend toward making use of cloud services, Software-as-a-Service (SaaS) solutions, and other technical innovations such as use of Artificial Intelligence (AI), Machine Learning (ML) and Large Language Models (LLMs), such as ChatGPT that have more recently begun to be used more heavily in life science companies.
Webinars
Dietary Supplement Finished Product Testing and Specifications
Presented by Shelly BlackwellThursday, April 16, 2026 | 3:00 PM ETThe FDA requires that dietary supplement manufactures establish finished product specifications and test to ensure the specifications are met. However, the process of implementing this requirement is...
On Demand Webinars
cGMP Responsibilities for Own Label Distributors and Brand Owners
This webinar will help you understand how to meet the requirements of an Own Label Distributor and comply with FDA regulations.
Latest News
FDA Finalizes Rule Standardizing National Drug Code Format
FDA Final Rule Revises National Drug Code Format and Barcode Requirements FDA has issued a final rule revising the format of the National Drug Code (NDC) and updating certain drug label barcode...
FDA Issues Guidance on Responding to Form 483 Observations Following Drug CGMP Inspections
FDA Releases Guidance on Responding to Form 483 Observations The U.S. Food and Drug Administration has issued a guidance document titled “Responding to FDA Form 483 Observations at the Conclusion of...
FDA Announces Public Meeting on Dietary Supplement Innovation and Ingredient Scope
FDA to Hold Public Meeting on Dietary Supplement Innovation and Ingredient Scope The U.S. Food and Drug Administration has announced an upcoming public meeting focused on dietary supplement...
Get the Newsletter
Subscribe to EASeNews and join the nearly 20,000 who receive the monthly EASeNews regulatory newsletter.
Got a Question?
Contact Us Today for a Complimentary Consultation!